Compare Stocks

→ What is the 72-Hour Profit Surge? (From DTI) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ABCN VIVO Cannabis	C$1.32 +5.6%	C$1.32	C$0.80 ▼ C$4.06	C$256.62M	N/A	1.51 million shs	310,601 shs
ATTBF Abattis Bioceuticals		$0.00	$0.00 ▼ $0.00	N/A	N/A	11,650 shs	2,500 shs
IPATF ImmunoPrecise Antibodies	$1.19 -2.5%	$1.56	$1.15 ▼ $20.25	N/A	N/A	20,327 shs	126,824 shs

(Almost) Everything You Need To Know About The EV Market

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ABCN VIVO Cannabis	0.00%	0.00%	0.00%	0.00%	0.00%
ATTBF Abattis Bioceuticals	0.00%	0.00%	0.00%	0.00%	0.00%
IPATF ImmunoPrecise Antibodies	0.00%	-3.94%	-19.74%	-21.18%	-57.93%

Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (Ad)

The latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty.

See why the elites are pouring billions into gold.

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
ABCN VIVO Cannabis	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
ATTBF Abattis Bioceuticals	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
IPATF ImmunoPrecise Antibodies	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ABCN VIVO Cannabis	N/A	N/A	N/A	N/A
ATTBF Abattis Bioceuticals	N/A	N/A	N/A	N/A
IPATF ImmunoPrecise Antibodies	N/A	N/A	N/A	N/A

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ABCN VIVO Cannabis	N/A	N/A	N/A	N/A	N/A	N/A
ATTBF Abattis Bioceuticals	N/A	N/A	N/A	N/A	N/A	N/A
IPATF ImmunoPrecise Antibodies	N/A	N/A	N/A	N/A	N/A	N/A

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ABCN VIVO Cannabis	N/A	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A
ATTBF Abattis Bioceuticals	N/A	-$0.16	N/A	N/A	N/A	N/A	N/A	N/A	N/A
IPATF ImmunoPrecise Antibodies	N/A	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
ABCN VIVO Cannabis	N/A	N/A	N/A	N/A	N/A
ATTBF Abattis Bioceuticals	N/A	N/A	N/A	N/A	N/A
IPATF ImmunoPrecise Antibodies	N/A	N/A	N/A	N/A	N/A

Ownership

Institutional Ownership

Company	Institutional Ownership
ABCN VIVO Cannabis	N/A
ATTBF Abattis Bioceuticals	32.45%
IPATF ImmunoPrecise Antibodies	N/A

Insider Ownership

Company	Insider Ownership
ABCN VIVO Cannabis	N/A
ATTBF Abattis Bioceuticals	N/A
IPATF ImmunoPrecise Antibodies	N/A

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
ABCN VIVO Cannabis	N/A	194.41 million	N/A	Not Optionable
ATTBF Abattis Bioceuticals	N/A	N/A	N/A	Not Optionable
IPATF ImmunoPrecise Antibodies	N/A	N/A	N/A	Not Optionable

IPATF, ATTBF, ABCN, ABZA, and AHZ Headlines

Source	Headline
	ImmunoPrecise Antibodies (OTCMKTS:IPATF) Trading Up 4% americanbankingnews.com - April 17 at 1:50 AM
	EXCLUSIVE: Immunoprecise Antibodies and InterSystems Integrate Vector Search With LENSai For AI-Driven Healthcare Applications benzinga.com - March 28 at 7:50 AM
	ImmunoPrecise Antibodies (NASDAQ: IPA) Is Changing How We Look At The Complex World Of Antibody Discovery benzinga.com - February 12 at 8:54 AM
	Immunoprecise Antibodies announces collaboration with Xyphos on antibodies against TME target bioworld.com - April 3 at 12:07 AM
	ImmunoPrecise Antibodies' Subsidiary Talem Therapeutics Announces a Multi-Target AI-Driven Antibody Discovery Collaboration with Libera Bio stockhouse.com - March 17 at 9:47 AM
	Transporting antibodies across the blood–brain barrier to treat Alzheimer's disease phys.org - March 11 at 5:53 PM
	Sugar-coated antibodies cross blood-brain barrier to fight Alzheimer's newatlas.com - March 11 at 5:53 PM
	An antibody injection could one day help people with endometriosis sciencenews.org - March 11 at 5:53 PM
	Check this out: Researchers design new approach to creating antibody libraries hub.jhu.edu - March 8 at 7:22 AM
	The antibodies from camels and sharks that could change medicine medicalxpress.com - March 1 at 12:25 PM
	First COVID-19 vaccination can 'hurt' subsequent boosters, study shows sciencedaily.com - February 26 at 11:53 AM
	New artificial model validates antibodies' ability to reach the brain medicalxpress.com - February 26 at 6:53 AM
	Multiple mutations may help omicron variant escape antibodies phys.org - February 24 at 9:24 AM
	Small Wonders: The Antibodies From Camels and Sharks That Could Change Medicine medscape.com - February 23 at 6:23 PM
	Researchers make major advance with cancer-killing antibody-drug conjugates medicalxpress.com - February 22 at 10:00 PM
	The dark side of treating COVID-19 with monoclonal antibodies medicalxpress.com - February 19 at 9:03 PM
	What Happened to the Monoclonal Antibodies for COVID-19? medpagetoday.com - February 16 at 8:49 PM
	ImmunoPrecise Antibodies reports FQ1 results seekingalpha.com - September 15 at 6:17 PM

New MarketBeat Followers Over Time

Company Descriptions

VIVO Cannabis

CVE:ABCN

ABcann Global Corporation manufactures and distributes medical cannabis. The company is headquartered in Napanee, Canada.

Abattis Bioceuticals

OTCMKTS:ATTBF

Abattis Bioceuticals Corp. operates as a life sciences and biotechnology company in Canada. The company develops and licenses natural health products, medicines, extractions, and ingredients for the biological, nutraceutical, bioceutical, and cosmetic markets. It also provides Comfort, a cannabinoid enhanced nutraceutical for pain and inflammation; and Health-Canada licensed services for the cannabis industry. The company was formerly known as Abattis Biologix Corporation and changed its name to Abattis Bioceuticals Corporation in September 2012. Abattis Bioceuticals Corp. was incorporated in 1997 and is headquartered in Vancouver, Canada.

ImmunoPrecise Antibodies

OTCMKTS:IPATF

ImmunoPrecise Antibodies Ltd. engages in the provision of human therapeutic antibody discovery and development services. It offers a selection of antibodies, enzymes, enzymes activity assays, arthritis animal products, proteins, deiminated proteins, and hybridoma licensing for research purposes. Its services include B cell sorting, screening and sequencing; custom, immune and naive phage display production and screening; bi-specific, tri-specific, VHH, and VNAR antibody manufacturing; antibody engineering; and antibody optimization and humanization. The company was founded by Robert Beecroft on November 22, 1983 and is headquartered in Victoria, Canada.

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial